Cargando…
Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial
BACKGROUND: Few data are available from randomised trials about the effect of thrombolysis with alteplase on long-term functional outcome in patients who have had acute ischaemic stroke and no trial has reported effects on health-related quality of life. A secondary objective of the third Internatio...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Lancet Pub. Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854835/ https://www.ncbi.nlm.nih.gov/pubmed/23791822 http://dx.doi.org/10.1016/S1474-4422(13)70130-3 |
Ejemplares similares
-
The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke
por: Sandercock, Peter, et al.
Publicado: (2008) -
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
por: Sandercock, Peter, et al.
Publicado: (2011) -
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
Publicado: (2012) -
Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial
Publicado: (2015) -
Bolus-Infusion Delays of Alteplase during Thrombolysis in Acute Ischaemic Stroke and Functional Outcome at 3 Months
por: Acheampong, Paul, et al.
Publicado: (2014)